Related Experiment Videos
Continuous arteriovenous hemofiltration
1Department of Internal Medicine, Ohio State University Hospitals, Columbus.
Insights
Continuous venovenous hemofiltration (CAVH) offers gradual fluid management for critically ill patients. Newer techniques and CAVH with dialysis (CAVHD) enhance its effectiveness and urea clearance.
Area of Science:
- Nephrology
- Critical Care Medicine
- Intensive Care Unit (ICU) Procedures
Background:
- Critically ill patients often experience fluid and electrolyte imbalances.
- Bedside dialysis offers a crucial treatment option for these patients.
Purpose of the Study:
- To review the advantages and disadvantages of Continuous Arterio-Venous Hemofiltration (CAVH).
- To discuss the technical developments and future directions of CAVH.
- To introduce Continuous Arterio-Venous Hemodiafiltration (CAVHD) as an advancement.
Main Methods:
- Review of existing literature on CAVH.
- Analysis of the benefits and drawbacks of CAVH therapy.
- Discussion of emerging technical improvements and clinical tactics.
- Introduction of CAVHD as a subsequent development.
Main Results:
- CAVH provides gradual, continuous therapy, ideal for hemodynamically unstable patients.
- Key benefits include fluid balance control and ease of ICU administration.
- Disadvantages involve arterial access, anticoagulation, infection risk, and volume depletion.
- Technical advancements and specific clinical tactics can improve CAVH effectiveness.
Conclusions:
- CAVH is a valuable bedside dialysis technique for critically ill patients.
- Ongoing technical innovations are enhancing CAVH efficacy.
- CAVHD represents the next evolution, offering improved urea clearance alongside CAVH benefits.
Abstract:
CAVH is a bedside form of dialysis that is used in the treatment of fluid and electrolyte disorders seen in critically ill patients. The major advantages of the procedure include (1) gradual, continuous therapy, which is ideal in hemodynamically unstable patients; (2) control of fluid balance; and (3) ease of administration in the ICU. The major disadvantages of CAVH include (1) a requirement for arterial access, (2) the need for anticoagulation, (3) the risks of infection from long-term indwelling vascular lines, and (4) the potential for significant volume depletion. The effectiveness of CAVH may continue to improve owing to technical developments in filter composition and the application of clinical tactics such as suction-assisted filtration, predilution fluid replacement, or regional heparinization. The next step in bedside dialysis is represented by CAVHD, which offers all of the advantages of CAVH as well as improved urea clearance.